NPI registry status
Active
2026 NPPES data Cardiovascular Disease Physician NPI 1306977186 MD
Verify on CMS → Laura Galindez Matos, MD
Cardiovascular Disease Physician in San Juan, Puerto Rico.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 24,795 in Cardiovascular Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 133 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Laura Galindez Matos, MD filed 1,814 Medicare Part D claims in 2023 as a Cardiovascular Disease Physician in San Juan, Puerto Rico, prescribing 85% generic.
- 2K
- Part D claims, 2023
- 85%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Laura Galindez Matos, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
1,814 Top 17% higher than 83% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
◑
Board-eligible specialty (heuristic, not verified)
Laura Galindez Matos, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Laura Galindez Matos, MD?
Quality data not reportedPrimary specialty
Cardiovascular Disease Physician
Medicare Part D claims
1,814 40% vs specialty avg
Specialty distribution in Puerto Rico
How Cardiovascular Disease Physician compares to other specialties among Puerto Rico providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Cardiovascular Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Laura Galindez Matos, MD appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding MD credentials at LA RIVIERA, San Juan, PR, 00921, with a listed phone of (787) 707-7854. NPI 1306977186 was issued on 03/07/2007.
Medicare Part D records for calendar year 2023 show 1,814 prescription claims written by this provider, covering 133 Medicare beneficiaries and totaling roughly $139K in drug spend, split 15% brand-name and 85% generic by claim count.
Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1306977186 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 03/07/2007 |
Brand vs generic prescribing mix · Typical
Laura Galindez Matos, MD - brand share 15.0%
Cardiovascular Disease Physician average
15% brand-name claims vs 85% generic, on 1,814 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,814
Total Claims
$139K
Total Drug Cost
133
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,479
- Total Day Supply
- 73,580
- Brand vs Generic
- 15% brand / 85% generic
- Brand Drug Cost
- $106K
- Generic Drug Cost
- $33K
Patient Demographics
- Average Patient Age
- 73.3 years
- Avg HCC Risk Score
- 1.74
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 15, 65-74: 53, 75-84: 54, 85+: 11
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Laura Galindez Matos, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Rosuvastatin Calcium
Rosuvastatin Calcium
153 claims
- Atorvastatin Calcium
Atorvastatin Calcium
121 claims
- Metoprolol Succinate
Metoprolol Succinate
121 claims
- Candesartan Cilexe…
Candesartan Cilexetil
106 claims
- Ezetimibe
Ezetimibe
80 claims
- Pantoprazole Sodium
Pantoprazole Sodium
79 claims
- Clopidogrel
Clopidogrel
68 claims
- Candesartan-Hydroc…
Candesartan-Hydrochlorothiazid
66 claims
| Drug | Claims |
|---|---|
| Rosuvastatin Calcium | 153 |
| Atorvastatin Calcium | 121 |
| Metoprolol Succinate | 121 |
| Candesartan Cilexetil | 106 |
| Ezetimibe | 80 |
| Pantoprazole Sodium | 79 |
| Clopidogrel Clopidogrel Bisulfate | 68 |
| Candesartan-Hydrochlorothiazid Candesartan/Hydrochlorothiazid | 66 |
| Losartan Potassium | 65 |
| Xarelto Rivaroxaban | 60 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cardiovascular Disease Physician Overview
How Laura Galindez Matos, MD fits within the Cardiovascular Disease Physician landscape nationally.
24,795
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider
Laura Galindez Matos, MD's 1,814 claims are below the specialty average of 3,033.
Nearby Cardiovascular Disease Physician Providers in Puerto Rico
Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as Galindez Matos.
Dr. Jose Acevedo-Valles
MD
San Juan, PR
Dr. Gerardo Alayon Anta
M.D.
Ponce, PR
Dr. Edwin Alejandro
MD
Bayamon, PR
Dr. Angel Arroyo
MD
Rio Piedras, PR
Dr. Victor Arroyo
MD
Carolina, PR
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Puerto Rico medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Cardiovascular Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Puerto Rico
Frequently Asked Questions
What is Laura Galindez Matos, MD's specialty? ▼
Laura Galindez Matos, MD specializes in Cardiovascular Disease Physician and practices in San Juan, Puerto Rico. Credentials: MD.
How much does Laura Galindez Matos, MD prescribe under Medicare Part D? ▼
In 2023, Laura Galindez Matos, MD wrote 1,814 Medicare Part D claims totaling $139K in drug costs for 133 beneficiaries.
Where is Laura Galindez Matos, MD located? ▼
Laura Galindez Matos, MD is located at LA RIVIERA, San Juan, PR, 00921. Phone: (787) 707-7854.
What is Laura Galindez Matos, MD's NPI number? ▼
Laura Galindez Matos, MD's National Provider Identifier (NPI) is 1306977186, issued on 03/07/2007.
Does Laura Galindez Matos, MD prescribe more brand-name or generic drugs? ▼
Laura Galindez Matos, MD's prescribing is 15% brand-name and 85% generic drugs by claim count, with $106K in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US? ▼
There are 24,795 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does Laura Galindez Matos, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Laura Galindez Matos, MD's most frequently prescribed drugs include Rosuvastatin Calcium, Atorvastatin Calcium, Metoprolol Succinate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Laura Galindez Matos, MD accept Medicare? ▼
Laura Galindez Matos, MD appears in CMS Medicare data with 1,814 Part D claims and 133 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Laura Galindez Matos, MD's credentials? ▼
Laura Galindez Matos, MD's NPI is 1306977186 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.